QuickView for CTNNB1;jsessionid=3CA831FEA6DBEDA7EE44CC58C4043ACE;jsessionid=8C29D5BDB326BCF77D274BB5A118433D;jsessionid=472FDC6B2F213E7CB9B164B789AB67EB;jsessionid=2BE04786F2667E4CD9F33F7F7D5B0AB2 (gene)

1. β-catenin inhibitors in cancer therapeutics: intricacies and way forward.
2. Novel truncating variants in CTNNB1 cause familial exudative vitreoretinopathy.
3. Crosstalk Between β-CATENIN-Mediated Cell Adhesion and the WNT Signaling Pathway.
4. SETDB1 confers colorectal cancer metastasis by regulation of WNT/β-catenin signaling.
5. Characterization of the Subcellular Distribution of Phospho-β-catenin in Colorectal Cancer.

There were no clinical trials for CTNNB1;jsessionid=3CA831FEA6DBEDA7EE44CC58C4043ACE;jsessionid=8C29D5BDB326BCF77D274BB5A118433D;jsessionid=472FDC6B2F213E7CB9B164B789AB67EB;jsessionid=2BE04786F2667E4CD9F33F7F7D5B0AB2